-
New Track: Japanese Digital Therapeutics for Hypertension Achieves Success in Phase III Clinical Trial
PharmaSources/Xiaoyaowan
April 07, 2021
The Japanese company CureApp has recently announced the results of a Phase III multicenter randomized controlled clinical trial of their digital therapeutics for hypertension, which was jointly researched by CureApp and a team led ...
-
Digbi Health Protects Teachers By Reducing High Risk Comorbidities Associated With COVID19 As Schools Open For In-Person Learning
prnewswire
August 19, 2021
Digbi Health, an artificial intelligence (AI) powered, precision digital therapeutics platform that uses gut microbiome and host genetic information to cure physical and mental illnesses, is helping educators fight obesity and COVID-19 related risks.
-
DarioHealth partners with the American Diabetes Association
biospectrumasia
May 06, 2019
DarioHealth's mission is to support people with diabetes and other chronic conditions in the U.S. and around the world
-
Akili, Shionogi to develop digital therapeutics in key Asian markets
biospectrumasia
March 11, 2019
Akili Interactive and Shionogi & Co. have announced that they have entered into a strategic partnership for the commercialization of Akili’s digital medicines, AKL-T01 and AKL-T02, in Japan and Taiwan, China region in China.
-
Cipla taps Wellthy for digital therapeutics expertise
pharmaphorum
February 20, 2019
Indian pharma company Cipla has made another play in the digital medicine category by taking a near-12% stake in start-up Wellthy Therapeutics.
-
Otsuka and Click Therapeutics Collaborate to Develop and Commercialize Digital Therapeutics for Patients with Major Depressive Disorder
pharmafocusasia
January 07, 2019
Otsuka America, Inc., and Click Therapeutics, Inc., announce today that the companies have signed a collaboration agreement to develop and commercialize a prescription digital therapeutic for .....